No abstract

Objective: The present study was done to see the effect of biologically synthesized CuO-NPs (Copperoxide nanoparticles) on the growth of bacterial strains. Methods: Physico-chemical characterization of CuO-NPs was done by UV-Vis-spectrophotometer, XRD, FE-SEM, and EDS. The disc plate diffusion assay was used to evaluate the anti-bacterial effect of CuNPs. Results: This study has shown a promising anti-bacterial activity of biosynthesized CuO-NPs at different concentrations ranging from 10 to 100 µg/ml against Escherichia coli and Staphylococcus aureus bacteria. Conclusion: Nanoparticles (NPs) are small size particles between range 1 to 100 nm which expand their physical and chemical properties due to high surface area. The present study reveals that there may be possible utilization of biosynthesized CuO NPs for the treatment of bacterial infectious disease in near future.

No abstract

A novel series of 3-(4-aryl)-4-(4,5-diphenyl-1H-imidazol-2-yl)-1-phenyl-1H-pyrazole was synthesized by employing the well-known Debus-Radziszewski reaction. Structures of all the newly synthesized compounds have been characterized by various spectroscopic techniques viz. FTIR, 1H and 13C NMR, LC-MS and elemental analysis. All these compounds were also screened for antimicrobial potential against bacterial strains of S. aureus, K. pneumoniae and fungal strains of A. niger and T. rubrum.

Aim: The present study was designed to synthesize novel Schiff bases and their metal complexes with promising antimicrobial and anti-angiogenic potential. Background: Currently, drug resistance has been seen in a diverse range of microbes, which is considered a major threat to widespread infectious diseases. Therefore, it is essential to investigate novel therapeutic molecules with broad-spectrum activities. Method: The novel Schiff base ligands were synthesized by using a condensation reaction of ethylenediamine with p-chloroacetanilide and p-bromoactanilide. Fe(III), Ni(II), Mn(II), and Co(II) metal complexes were prepared by refluxing the ligand with respective metal chloride salts in a 2:1 molar ratio. Results: Structures of the synthesized compounds were characterized by IR, 1H NMR, UV-VIS, and mass spectrometry. Anti-microbial activities of all the synthesized compounds were determined against bacterial strains (S. aureus and K. pneumoniae) and fungal strains (A. niger and Trichophytonrubrum) by using the well plate diffusion method. DNA photo-cleavage and anti-angiogenic properties were evaluated by gel electrophoresis and CAM assay, respectively. Molecular docking studies were performed to analyze the binding interactions of synthesized compounds with topoisomerase II alpha. Conclusion: The present preliminary efforts may be helpful to design novel drugs with therapeutic potential.